Selank Spray10mg
Selank Spray Canada — Nasal Spray
Synthetic Heptapeptide Research Compound
Selank Spray is a nasal delivery format of the Selank peptide studied in laboratory settings for its interaction with neuroregulatory and stress-response signaling pathways. Research typically explores its effects on cognitive-related mechanisms, receptor activity, and systemic absorption dynamics when administered via intranasal models.
This product is intended strictly for laboratory research use within Canada. It is not approved by Health Canada for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable Canadian regulations.
Selank is a synthetic heptapeptide derived from the endogenous tetrapeptide tuftsin with structural modifications for enhanced stability in experimental systems. It is developed for controlled laboratory research involving neuropeptide signaling pathways.
In scientific literature, Selank is studied in models examining neurotransmitter-associated signaling frameworks, receptor-mediated regulatory systems, and central nervous system pathway interaction under in vitro and preclinical research conditions.
Selank is a modified peptide analogue evaluated in research focused on neuropeptide signaling and central regulatory pathway interaction. Experimental studies examine its interaction within neurotransmitter-associated frameworks and receptor-mediated signaling systems under controlled laboratory conditions.
Research publications have explored its signaling profile and pathway-level regulatory characteristics within structured experimental environments.
Selank was developed through investigations into synthetic analogues of tuftsin designed to enhance stability and signaling properties. Research expanded into neuropeptide interaction models and central signaling system frameworks within laboratory environments.
Subsequent studies documented its regulatory pathway interaction and peptide signaling behavior in experimental research systems.
Laboratory investigations into Selank have focused on neuropeptide signaling models and receptor-mediated pathway interaction systems. Research frameworks evaluate peptide stability, central regulatory dynamics, and neurotransmitter-associated signaling mechanisms under controlled in vitro and preclinical conditions.
1 of the 4 areas below are addressed directly by a paper cited on this page.
No paper cited on this page reports on neuropeptide. This heading marks where Selank Spray is discussed in the category rather than a question the cited literature answers, and it is worth knowing which of these areas has work behind it and which does not.
Addressed on this page by Konstantinopolsky 2022, Kolik 2019, Vanhee 2020. The work appeared in Drug Test Anal. Each is linked to its source record in the references below, so what was measured — and in what system — can be read rather than taken on trust.
No paper cited on this page reports on central or nervous. This heading marks where Selank Spray is discussed in the category rather than a question the cited literature answers, and it is worth knowing which of these areas has work behind it and which does not.
No paper cited on this page reports on receptor or mediated. This heading marks where Selank Spray is discussed in the category rather than a question the cited literature answers, and it is worth knowing which of these areas has work behind it and which does not.
The references section of this page cites 4 primary papers published between 2019 and 2022 — a limited but non-trivial record. Every citation is linked to its PubMed or DOI record so it can be read rather than taken on trust, and the summaries above describe what those papers report rather than what the compound is claimed to do.
Research compounds attract claims that outrun their evidence. Below are the ones most often encountered for Selank Spray, set against what the papers cited on this page actually report. Where the record is thin or contested, that is stated rather than smoothed over.
Selank Spray is also referred to as selank.
Selank Spray is commonly described online in connection with sharper focus, better memory and improved mood. In the research literature the same compound is filed under neuropeptide signaling pathway models, tuftsin-derived peptide research frameworks and central nervous system pathway investigations.
The 4 papers cited on this page, published between 2019 and 2022 (2 in animal models) describe laboratory and animal work. None reports a controlled trial in humans. Findings in cell culture or in a rodent model describe what happened in that system; they do not establish that the same occurs in humans, and this compound is not approved for human use.
Nothing above is a statement of what this material does. It is a summary of what has been published and what has not. Eppix Labs supplies research materials only and provides no dosing, administration or protocol guidance.
Verification for Selank Spray is per lot, not per product. The current 10mg lot SLNK-CA-26F-10 returned 99.161% purity, 10.55 mg measured, 105.5% of the labelled 10 mg, assayed by Janoshik. Those figures are the laboratory's, published in full rather than reduced to a badge.
The lot code printed on the vial matches the code on the certificate for Selank Spray. Matching the two is what confirms the unit in hand came from the batch that was tested — a certificate not tied to a lot code proves nothing about any particular unit.
Researchers who buy Selank Spray in Canada through Eppix Labs receive the lot described by the certificate above: the code printed on the vial label is the code on the certificate, and both are searchable on the batch verification page.
Selank Spray ships as a prepared solution rather than as lyophilized powder, so it is already past the point at which a powder would be reconstituted. That shortens handling but tightens storage: a compound in solution is less stable than the same compound dry, and refrigeration from arrival onward is the relevant control.
The stability window for a solution is shorter than the shelf life of a sealed lyophilized vial of the same compound. Records for laboratory work in this format should note the date the unit was opened, not only the date it was received.
Vials may appear empty on arrival. Lyophilized material collects at the base of the vial and is often not visible until the vial is inspected under direct light.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each unit contains 12mg of Selank in a 12 mL spray presentation delivering 120 mcg per spray. Independent third-party testing verifies purity, identity, and batch specifications.
The product is supplied in a ready-to-use research presentation. No additional laboratory materials are included.
Duration depends entirely on research protocol, storage conditions, and laboratory application.
Selank, a Peptide Analog of Tuftsin, Attenuates Aversive Signs of Morphine Withdrawal in Rats.
PubMedThe Influence of Selank on the Level of Cytokines Under the Conditions of "Social" Stress. Curr Rev Clin Exp Pharmacol 16(2):169–173.
PubMedSelank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating BDNF Content in the Hippocampus and Prefrontal Cortex in Rats.
PubMedThe occurrence of putative cognitive enhancing research peptides in seized pharmaceutical preparations: An incentive for controlling agencies to prepare for future encounters of the third kind. Drug Test Anal 12(1):63–73.
PubMedRelated
Eppix Flash Sale −30%Peptides
Triple GIP / GLP-1 / Glucagon Agonist · 10, 20, 40 & 120 mg Retatrutide is a synthetic peptide developed for controlled laboratory research involving multi-receptor signaling systems. It is structurally designed to interact with GLP-1, GIP, and glucagon receptor pathways within experimental environments.
RETA-CA-26F-1099.637%
11.76 mg / 10 mg
$41.96$59.95CAD
Flash sale ends in
Eppix Flash Sale −30%Peptides
Dual GIP / GLP-1 Agonist · 10, 30 & 65 mg Tirzepatide is a synthetic peptide developed for controlled laboratory research involving dual incretin receptor signaling systems. It is structurally designed to interact with GLP-1 and GIP receptor pathways within experimental environments.
TIRZ-CA-26G-1099.634%
11.42 mg / 10 mg
$24.46$34.95CAD
Flash sale ends in
Eppix Flash Sale −30%Peptides
GLP-1 Receptor Agonist · 10 mg Semaglutide is a synthetic analogue of glucagon-like peptide-1 (GLP-1), a naturally occurring incretin hormone involved in glucose-dependent signaling. It is developed for controlled laboratory investigation within regulated experimental environments.
10 mgSEMA-CA-26F-1099.504%
11.27 mg / 10 mg
$38.46$54.95CAD
Flash sale ends in
Eppix Flash Sale −30%Peptides
Selective Amylin Agonist (LY3841136) · 10 mg This product is supplied as eloralintide (LY3841136), a long-acting, selective amylin receptor agonist studied in research on metabolic and body-weight regulation.
10 mgELOR-CA-26G-1099.810%
12.42 mg / 10 mg
$101.46$144.95CAD
Flash sale ends in
